Sylwia Mazurek

Dr. Sylwia Mazurek

Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan 61-701, Poland.
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Cell
Verified
Journal Article
Open access
TMTathiane M. Malta
Tathiane M. Malta
ASArtem Sokolov
Artem Sokolov
AGAndrew J. Gentles
Andrew J. Gentles
TBTomasz Burzykowski
Tomasz Burzykowski
LPLaila Poisson
Laila Poisson
AMArmaz Mariamidze
Armaz Mariamidze
Cancer progression involves the gradual loss of a differentiated phenotype and acquisition of progenitor and stem-cell-like features. Here, we provide novel stemness indices for assessing the degree of oncogenic dedifferentiation. We used an innovative one-class logistic regression (OCLR) machine-learning algorithm to extract transcriptomic and epigenetic feature sets derived from non-transformed pluripotent stem cells and their differentiated progeny. Using OCLR, we were able to identify previously undiscovered biological mechanisms associated with the dedifferentiated oncogenic state. Analyses of the tumor microenvironment revealed unanticipated correlation of cancer stemness with immune checkpoint expression and infiltrating immune cells. We found that the dedifferentiated oncogenic phenotype was generally most prominent in metastatic tumors. Application of our stemness indices to single-cell data revealed patterns of intra-tumor molecular heterogeneity. Finally, the indices allowed for the identification of novel targets and possible targeted therapies aimed at tumor differentiation.

29 August 2017 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
PCPatrycja Czerwinska
Patrycja Czerwinska
SMSylwia Mazurek
Sylwia Mazurek
MWMaciej Wiznerowicz
Maciej Wiznerowicz
Since the first discovery in 1996, the engagement of TRIM28 in distinct aspects of cellular biology has been extensively studied resulting in identification of a complex nature of TRIM28 protein. In this review, we summarize core biological functions of TRIM28 that emerge from TRIM28 multi-domain structure and possessed enzymatic activities. Moreover, we will discuss whether the complexity of TRIM28 engagement in cancer biology makes TRIM28 a possible candidate for targeted anti-cancer therapy. Briefly, we will demonstrate the role of TRIM28 in regulation of target gene transcription, response to DNA damage, downregulation of p53 activity, stimulation of epithelial-to-mesenchymal transition, stemness sustainability, induction of autophagy and regulation of retrotransposition, to provide the answer whether TRIM28 functions as a stimulator or inhibitor of tumorigenesis. To date, number of studies demonstrate significant upregulation of TRIM28 expression in cancer tissues which correlates with worse overall patient survival, suggesting that TRIM28 supports cancer progression. Here, we present distinct aspects of TRIM28 involvement in regulation of cancer cell homeostasis which collectively imply pro-tumorigenic character of TRIM28. Thorough analyses are further needed to verify whether TRIM28 possess the potential to become a new anti-cancer target.

10 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
PCPatrycja Czerwinska
Patrycja Czerwinska
PSParantu K. Shah
Parantu K. Shah
KTKatarzyna Tomczak
Katarzyna Tomczak
MKMarta Klimczak
Marta Klimczak
SMSylwia Mazurek
Sylwia Mazurek
MWMaciej Wiznerowicz
Maciej Wiznerowicz
TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development TRIM28 multi-domain protein regulates Cancer Stem Cell population in breast tumor development

1 January 2015 in Contemporary Oncology
Verified
Journal Article
Open access
KKKatarzyna Kulcenty
Katarzyna Kulcenty
JWJoanna Wróblewska
Joanna Wróblewska
SMSylwia Mazurek
Sylwia Mazurek
ELEwa Liszewska
Ewa Liszewska
JJJacek Jaworski
Jacek Jaworski
Growing knowledge concerning transcriptional control of cellular pluripotency has led to the discovery that the fate of differentiated cells can be reversed, which has resulted in the generation, by means of genetic manipulation, of induced pluripotent stem cells. Overexpression of just four...